statistiche ricercatore

Continente	#
NA - Nord America	887
AS - Asia	779
EU - Europa	271
SA - Sud America	97
AF - Africa	8
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.043

Nazione	#
US - Stati Uniti d'America	854
CN - Cina	266
SG - Singapore	264
BR - Brasile	80
HK - Hong Kong	73
GB - Regno Unito	52
IT - Italia	52
KR - Corea	48
BD - Bangladesh	43
VN - Vietnam	40
FI - Finlandia	35
RU - Federazione Russa	27
SE - Svezia	26
DE - Germania	23
CA - Canada	16
FR - Francia	13
LT - Lituania	13
AR - Argentina	7
IN - India	7
IQ - Iraq	6
NL - Olanda	6
IL - Israele	5
JP - Giappone	5
ZA - Sudafrica	5
IE - Irlanda	4
PE - Perù	4
PK - Pakistan	4
CR - Costa Rica	3
EC - Ecuador	3
HN - Honduras	3
MX - Messico	3
PT - Portogallo	3
UA - Ucraina	3
AL - Albania	2
LA - Repubblica Popolare Democratica del Laos	2
NI - Nicaragua	2
OM - Oman	2
PA - Panama	2
PL - Polonia	2
QA - Qatar	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BG - Bulgaria	1
BO - Bolivia	1
BS - Bahamas	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
HU - Ungheria	1
IS - Islanda	1
KG - Kirghizistan	1
LK - Sri Lanka	1
LV - Lettonia	1
MA - Marocco	1
NP - Nepal	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
VE - Venezuela	1
Totale	2.042

Nome	#
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients	224
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes	191
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia	190
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients	175
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines	163
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside	163
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells	161
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation	160
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS	160
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells	158
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression	156
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia	142
Totale	2.043

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	89	0	0	0	4	9	20	1	14	16	3	8	14
2023/2024	113	3	5	6	21	17	11	21	2	5	0	15	7
2024/2025	586	10	3	0	37	109	87	15	30	91	15	98	91
2025/2026	952	85	87	122	106	110	41	91	21	57	90	43	99
2026/2027	303	36	82	62	88	35	0	0	0	0	0	0	0
Totale													2.043